PHARMAC swapping epilepsy drugs 'cannot be discounted' as a cause of deaths — neurologist

One News

4 March 2021 - An Auckland paediatric neurologist says PHARMAC's decision to switch to a generic version of an epilepsy drug in 2019 cannot be discounted as a cause of death.

Dr Cynthia Sharpe's comments come as part of the coronial inquest, led by Chief Coroner Deborah Marshall, into the deaths of six people who had switched to the drug known as Logem.

Read One News article

Michael Wonder

Posted by:

Michael Wonder